JAZZ logo

Jazz Pharmaceuticals (JAZZ) Working capital

annual working capital:

$3.59B+$1.69B(+89.10%)
December 31, 2024

Summary

  • As of today (June 14, 2025), JAZZ annual working capital is $3.59 billion, with the most recent change of +$1.69 billion (+89.10%) on December 31, 2024.
  • During the last 3 years, JAZZ annual working capital has risen by +$1.79 billion (+99.24%).
  • JAZZ annual working capital is now at all-time high.

Performance

JAZZ Working capital Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherJAZZbalance sheet metrics

quarterly working capital:

$2.91B-$685.25M(-19.09%)
March 1, 2025

Summary

  • As of today (June 14, 2025), JAZZ quarterly working capital is $2.91 billion, with the most recent change of -$685.25 million (-19.09%) on March 1, 2025.
  • Over the past year, JAZZ quarterly working capital has increased by +$927.51 million (+46.90%).
  • JAZZ quarterly working capital is now -19.09% below its all-time high of $3.59 billion, reached on December 31, 2024.

Performance

JAZZ quarterly working capital Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherJAZZbalance sheet metrics

Working capital Formula

Working Capital = Current Assets − Current Liabilities

JAZZ Working capital Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+89.1%+46.9%
3 y3 years+99.2%+64.8%
5 y5 years+183.7%+159.0%

JAZZ Working capital Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-yearat high+114.6%-19.1%+73.7%
5 y5-yearat high+183.7%-19.1%+159.0%
alltimeall timeat high+2872.7%-19.1%+2252.2%

JAZZ Working capital History

DateAnnualQuarterly
Mar 2025
-
$2.91B(-19.1%)
Dec 2024
$3.59B(+89.1%)
$3.59B(+6.8%)
Sep 2024
-
$3.36B(+58.1%)
Jun 2024
-
$2.13B(+7.5%)
Mar 2024
-
$1.98B(+4.2%)
Dec 2023
$1.90B(+13.5%)
$1.90B(+13.5%)
Sep 2023
-
$1.67B(-19.0%)
Jun 2023
-
$2.06B(+10.1%)
Mar 2023
-
$1.88B(+12.1%)
Dec 2022
$1.67B(-7.2%)
$1.67B(-4.9%)
Sep 2022
-
$1.76B(-6.7%)
Jun 2022
-
$1.89B(+6.9%)
Mar 2022
-
$1.76B(-2.1%)
Dec 2021
$1.80B(-17.6%)
$1.80B(-4.8%)
Sep 2021
-
$1.89B(-8.7%)
Jun 2021
-
$2.07B(-14.1%)
Mar 2021
-
$2.41B(+10.5%)
Dec 2020
$2.19B(+72.7%)
$2.19B(+14.2%)
Sep 2020
-
$1.91B(+1.1%)
Jun 2020
-
$1.89B(+68.7%)
Mar 2020
-
$1.12B(-11.4%)
Dec 2019
$1.27B(+42.5%)
$1.27B(+12.0%)
Sep 2019
-
$1.13B(+12.9%)
Jun 2019
-
$1.00B(+12.2%)
Mar 2019
-
$891.62M(+0.3%)
Dec 2018
$888.52M(+31.8%)
$888.52M(-20.9%)
Sep 2018
-
$1.12B(+17.1%)
Jun 2018
-
$958.98M(+27.7%)
Mar 2018
-
$750.70M(+11.3%)
Dec 2017
$674.33M(+37.4%)
$674.33M(+19.8%)
Sep 2017
-
$562.77M(+36.6%)
Jun 2017
-
$412.11M(+14.4%)
Mar 2017
-
$360.08M(-26.6%)
Dec 2016
$490.66M(-52.4%)
$490.66M(-4.0%)
Sep 2016
-
$511.37M(-49.1%)
Jun 2016
-
$1.00B(+15.2%)
Mar 2016
-
$871.79M(-15.4%)
DateAnnualQuarterly
Dec 2015
$1.03B(+29.0%)
$1.03B(+5.8%)
Sep 2015
-
$974.75M(-4.4%)
Jun 2015
-
$1.02B(+15.6%)
Mar 2015
-
$882.35M(+10.4%)
Dec 2014
$799.04M(+21.0%)
$799.04M(+22.0%)
Sep 2014
-
$654.78M(+88.6%)
Jun 2014
-
$347.14M(+24.3%)
Mar 2014
-
$279.31M(-57.7%)
Dec 2013
$660.59M(+83.5%)
$660.59M(+8.9%)
Sep 2013
-
$606.71M(+10.3%)
Jun 2013
-
$549.83M(+36.2%)
Mar 2013
-
$403.65M(+12.1%)
Dec 2012
$360.03M(+146.2%)
$360.03M(+74.4%)
Sep 2012
-
$206.44M(+90.9%)
Jun 2012
-
$108.12M(-51.4%)
Mar 2012
-
$222.56M(+52.2%)
Dec 2011
$146.26M(+907.2%)
$146.26M(+54.6%)
Sep 2011
-
$94.61M(+72.7%)
Jun 2011
-
$54.77M(+64.0%)
Mar 2011
-
$33.40M(+130.0%)
Dec 2010
$14.52M(-165.2%)
$14.52M(-160.0%)
Jun 2010
-
-$24.20M(-22.4%)
Mar 2010
-
-$31.17M(+39.9%)
Dec 2009
-$22.29M(-82.8%)
-$22.29M(+148.6%)
Sep 2009
-
-$8.97M(-48.7%)
Jun 2009
-
-$17.48M(-87.0%)
Mar 2009
-
-$134.99M(+4.2%)
Dec 2008
-$129.49M(-263.4%)
-$129.49M(-4067.3%)
Sep 2008
-
$3.26M(-3150.5%)
Jun 2008
-
-$107.00K(-100.2%)
Mar 2008
-
$44.52M(-43.8%)
Dec 2007
$79.23M(+29.8%)
$79.23M(-30.3%)
Sep 2007
-
$113.62M(-12.3%)
Jun 2007
-
$129.53M(+122.3%)
Mar 2007
-
$58.26M(-4.6%)
Dec 2006
$61.04M(+658.5%)
$61.04M(+658.5%)
Dec 2005
$8.05M
$8.05M

FAQ

  • What is Jazz Pharmaceuticals annual working capital?
  • What is the all time high annual working capital for Jazz Pharmaceuticals?
  • What is Jazz Pharmaceuticals annual working capital year-on-year change?
  • What is Jazz Pharmaceuticals quarterly working capital?
  • What is the all time high quarterly working capital for Jazz Pharmaceuticals?
  • What is Jazz Pharmaceuticals quarterly working capital year-on-year change?

What is Jazz Pharmaceuticals annual working capital?

The current annual working capital of JAZZ is $3.59B

What is the all time high annual working capital for Jazz Pharmaceuticals?

Jazz Pharmaceuticals all-time high annual working capital is $3.59B

What is Jazz Pharmaceuticals annual working capital year-on-year change?

Over the past year, JAZZ annual working capital has changed by +$1.69B (+89.10%)

What is Jazz Pharmaceuticals quarterly working capital?

The current quarterly working capital of JAZZ is $2.91B

What is the all time high quarterly working capital for Jazz Pharmaceuticals?

Jazz Pharmaceuticals all-time high quarterly working capital is $3.59B

What is Jazz Pharmaceuticals quarterly working capital year-on-year change?

Over the past year, JAZZ quarterly working capital has changed by +$927.51M (+46.90%)
On this page